Physiologically-based Kinetic Modelling (PBK Modelling): Meeting the 3Rs Agenda | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Modeling Interindividual Variation in Physiological Factors Used in PBPK Models of HumansOriginal Research · 2003 · 234 citations
2Extrapolation of physiological parameters for physiologically based simulation modelsRisk Assessment · 1995 · 26 citations
3A PBPK Modeling-Based Approach to Account for Interactions in the Health Risk Assessment of Chemical MixturesRisk Assessment · 2001 · 128 citations
4Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential—towards a consensusEarly-Phase Clinical Trial · 2001 · 284 citations
5Characterizing Uncertainty and Variability in Physiologically Based Pharmacokinetic Models: State of the Science and Needs for Research and ImplementationRisk Assessment · 2007 · 145 citations
6Framework for Evaluation of Physiologically‐Based Pharmacokinetic Models for Use in Safety or Risk AssessmentRisk Assessment · 2004 · 88 citations
7An analysis of recent animal use in the Republic of Korea, in an international context: Growth in animal procedures but no real progress on refinementAlternatives to Laboratory Animals · 2026
8AI-integrated human-relevant alternatives to animal experimentation in drug development: Toward a predictive translational ecosystem, from in vitro and in silico models to clinical and real-world evidenceAlternatives to Laboratory Animals · 2026
9Key challenges for in vitro testing of oral tobacco and nicotine products for regulatory applications: Recommendations for using in vitro toxicity and disease modelsAlternatives to Laboratory Animals · 2026
10Beyond rodents: A systematic review of antidepressant-like effects in Drosophila melanogaster as an alternative model in psychopharmacologyAlternatives to Laboratory Animals · 2026

More from Alternatives to Laboratory Animals

More from Imperial College London